Apollo Biowellness, Inc., Re-Engages GSS Capital

3 months ago

North Bergen, New Jersey--(Newsfile Corp. - October 8, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to…

Hazelden Betty Ford Recognized by Newsweek’s “America’s Best Addiction Treatment Centers 2025”

3 months ago

Addiction treatment and mental health system achieves top rankings in Minnesota, California and OregonCenter City, Minnesota; Rancho Mirage, California and…

Adia Nutrition Inc. Delivers Explosive Third Quarter Growth: Revenue Surges Over 100% from Prior Quarter, with Remarkable Profit Margin Exceeding 20%

3 months ago

Winter Park, Florida--(Newsfile Corp. - October 8, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a trailblazer in umbilical cord stem…

Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter

3 months ago

SEATTLE, WASHINGTON / ACCESS Newswire / October 8, 2025 / Aptevo Therapeutics ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology…

NeoPredics Announces Market Launch of PreFree Across CE-Markets

3 months ago

- Clinical challenge: uncertainty in discharge and admission decisions for women at risk of preeclampsia- PreFree: the first CE-marked, multimodal…

Rising Demand for Revision Rhinoplasty Leads Patients Worldwide to Dr. Shervin Naderi

3 months ago

The Naderi Center sees growing demand for revision rhinoplasty, with Dr. Shervin Naderi providing surgical and non-surgical solutions customized to…

Rezolut Launches SubtleHD: More Comfortable MRI Scans, Sharper Results

3 months ago

ATLANTA, GEORGIA / ACCESS Newswire / October 8, 2025 / Rezolut LLC, a national leader in advanced diagnostic imaging, is…

Leaders Named in Accountable Care and Value-Based Care Technology and Advisory Ecosystem

3 months ago

Black Book Survey results reveal the twenty-five firms shaping the next generation of accountable care infrastructure  released in orchestration with…

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

3 months ago

Study Demonstrated a Sensitivity of 100% and Specificity of 95%Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular…

PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists

3 months ago

TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology…